# Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

> **NCT01037842** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 145 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Mitiglinide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01037842
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-03
- **Final completion:** 2008-05
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2009-12-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037842, "Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01037842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*